Dynamic interplay of smooth muscle α-actin gene-regulatory proteins reflects the biological complexity of myofibroblast differentiation

Biology

Volumn 2, Issue 2, 2013, Pages 555-586

  Strauch, Arthur Roger ^a   Hariharan, Seethalakshmi ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Fibrosis; Gene transcription; Myofibroblast; Smooth muscle actin; Wound healing

Indexed keywords

EID: 84885621343     PISSN: None     EISSN: 20797737     Source Type: Journal    
DOI: 10.3390/biology2020555     Document Type: Review

References (146)

1. Hinz, B.; Phan, S.H.; Thannickal, V.J.; Prunotto, M.; Desmouliere, A.; Varga, J.; de Wever, O.; Mareel, M.; Gabbiani, G. Recent developments in myofibroblast biology: Paradigms for connective tissue remodeling. Am. J. Pathol. 2012, 180, 1340-1355.
2. Desmouliere, A.; Chaponnier, C.; Gabbiani, G. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen. 2005, 13, 7-12.
3. Gabbiani, G. The myofibroblast in wound healing and fibrocontractive diseases. J. Pathol. 2003, 200, 500-503.
4. Grinnell, F. Fibroblasts, myofibroblasts, and wound contraction. J. Cell Biol. 1994, 124, 401-404.
5. Odekon, L.E.; Blasi, F.; Rifkin, D.B. Requirement for receptor-bound urokinase in plasmindependent cellular conversion of latent TGF-β to TGF-β. J. Cell. Physiol. 1994, 158, 398-407.
6. Roberts, A.B. Molecular and cell biology of TGF-β. Miner. Electr. Metab. 1998, 24, 111-119.
7. Sheppard, D. Transforming growth factor beta: A central modulator of pulmonary and airway inflammation and fibrosis. Proc. Am. Thorac. Soc. 2006, 3, 413-417.
8. Chapman, H.A. Epithelial responses to lung injury. Proc. Am. Thorac. Soc. 2012, 9, 89-95.
9. Wipff, P.J.; Rifkin, D.B.; Meister, J.J.; Hinz, B. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J. Cell Biol. 2007, 179, 1311-1323.
10. Huang, X.; Gai, Y.; Yang, N.; Lu, B.; Samuel, C.S.; Thannickal, V.J.; Zhou, Y. Relaxin regulates myofibroblast contractility and protects against lung fibrosis. Am. J. Pathol. 2011, 179, 2751-2765.
11. Shi, Y.; Massague, J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113, 685-700.
12. Liu, X.; Kelm, R.J., Jr.; Strauch, A.R. Transforming growth factor β1-mediated activation of the smooth muscle α-actin gene in human pulmonary myofibroblasts is inhibited by tumor necrosis factor-α via mitogen-activated protein kinase kinase 1-dependent induction of the Egr-1 transcriptional repressor. Mol. Biol. Cell 2009, 20, 2174-2185.
13. Zhang, A.; Liu, X.; Cogan, J.G.; Fuerst, M.D.; Polikandriotis, J.A.; Kelm, R.J.J.; Strauch, A.R. YB-1 coordinates vascular smooth muscle α-actin gene activation by TGFβ1 and thrombin during differentiation of human pulmonary myofibroblasts. Mol. Biol. Cell 2005, 16, 4931-4940.
14. Subramanian, S.V.; Polikandriotis, J.A.; Kelm, R.J.J.; David, J.J.; Orosz, C.G.; Strauch, A.R. Induction of vascular smooth muscle alpha-actin gene transcription in transforming growth factor beta1-activated myofibroblasts mediated by dynamic interplay between the Pur repressor proteins and Sp1/Smad coactivators. Mol. Biol. Cell 2004, 15, 4532-4543.
15. Higashi, K.; Inagaki, Y.; Fujimori, K.; Nakao, A.; Kaneko, H.; Nakatsuka, I. Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3. J. Biol. Chem. 2003, 278, 43470-43479.
16. Small, E.M.; Thatcher, J.E.; Sutherland, L.B.; Kinoshita, H.; Gerard, R.D.; Richardson, J.A.; DiMaio, J.M.; Sadek, H.; Kuwahara, K.; Olson, E.N. Myocardin-related transcription factor-A controls myofibroblast activation and fibrosis in response to myocardial infarction. Circ. Res. 2010, 107, 294-304.
17. Tomasek, J.J.; Vaughan, M.B.; Kropp, B.P.; Gabbiani, G.; Martin, M.D.; Haaksma, C.J.; Hinz, B. Contraction of myofibroblasts in granulation tissue is dependent on Rho/Rho kinase/myosin light chain phosphatase activity. Wound Repair Regen. 2006, 14, 313-320.
18. Hinz, B.; Celetta, G.; Tomasek, J.J.; Gabbiani, G.; Chaponnier, C. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol. Biol. Cell 2001, 12, 2730-2741.
19. Dobaczewski, M.; Bujak, M.; Li, N.; Gonzalez-Quesada, C.; Mendoza, L.H.; Wang, X.F.; Frangogiannis, N.G. Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction. Circ. Res. 2010, 107, 418-428.
20. Chen, W.; Frangogiannis, N. The role of inflammatory and fibrogenic pathways in heart failure associated with aging. Heart Fail. Rev. 2010, 15, 415-422.
21. Leask, A. Potential therapeutic targets for cardiac fibrosis. Circ. Res. 2010, 106, 1675-1680.
22. Berk, B.C.; Fujiwara, K.; Lehoux, S. ECM remodeling in hypertensive heart disease. J. Clin. Invest. 2007, 117, 568-575.
23. Weber, K.T. Wound Healing in Cardiovascular Disease; Armonk Futura Publishing Co., Inc.: Armonk, NY, USA, 1995; pp. 1-320.
24. Duffield, J.S.; Lupher, M.; Thannickal, V.J.; Wynn, T.A. Host responses in tissue repair and fibrosis. Annu. Rev. Pathol. Mech. Dis. 2012, 8, 241-276.
25. Goodwin, A.; Jenkins, G. Role of integrin-mediated TGFbeta activation in the pathogenesis of pulmonary fibrosis. Biochem. Soc. Trans. 2009, 37, 849-854.
26. Wynn, T.A. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J. Clin. Invest. 2007, 117, 524-529.
27. Schmauss, D.; Weis, M. Cardiac allograft vasculopathy: Recent developments. Circulation 2008, 117, 2131-2141.
28. Demirci, G.; Nashan, B.; Pichlmayr, R. Fibrosis in chronic rejection of human liver allografts-Expression patterns of transforming growth factor-TGFβ1 and TGF-β3. Transplantation 1996, 62, 1776-1783.
29. Einecke, G.; Reeve, J.; Sis, B.; Mengel, M.; Hidalgo, L.; Famulski, K.S.; Matas, A.; Kasiske, B.; Kaplan, B.; Halloran, P.F. A molecular classifier for predicting future graft loss in late kidney transplant biopsies. J. Clin. Invest. 2010, 120, 1862-1872.
30. Armstrong, A.T.; Strauch, A.R.; Starling, R.C.; Sedmak, D.D.; Orosz, C.G. Morphometric analysis of neointimal formation in murine cardiac allografts. Transplantation 1997, 63, 941-947.
31. Armstrong, A.T.; Strauch, A.R.; Starling, R.C.; Sedmak, D.D.; Orosz, C.G. Morphometric analysis of neointimal formation in murine cardiac allografts. II. Rate and location of lesion formation. Transplantation 1997, 64, 322-328.
32. Armstrong, A.T.; Strauch, A.R.; Starling, R.C.; Sedmak, D.D.; Orosz, C.G. Morphometric analysis of neointimal formation in murine cardiac grafts. III. Dissociation of interstitial fibrosis from neointimal formation. Transplantation 1997, 64, 1198-1202.
33. David, J.J.; Subramanian, S.V.; Zhang, A.; Willis, W.L.; Kelm, R.J.; Leier, C.V.; Strauch, A.R. Y-box binding protein-1 implicated in translational control of fetal myocardial gene expression after cardiac transplant. Exp. Biol. Med. 2012, 237, 593-607.
34. Zhang, A.; David, J.J.; Subramanian, S.V.; Liu, X.; Fuerst, M.D.; Zhao, X.; Leier, C.V.; Orosz, C.G.; Kelm, R.J., Jr.; Strauch, A.R. Serum response factor neutralizes Pur alpha-and Pur beta-mediated repression of the fetal vascular smooth muscle alpha-actin gene in stressed adult cardiomyocytes. Am. J. Physiol. Cell Physiol. 2008, 294, C702-C714.
35. Subramanian, S.V.; Kelm, R.J., Jr.; Polikandriotis, J.A.; Orosz, C.G.; Strauch, A.R. Reprogramming of vascular smooth muscle alpha-actin gene expression as an early indicator of dysfunctional remodeling following heart transplant. Cardiovasc. Res. 2002, 54, 539-548.
36. Subramanian, S.V.; Orosz, C.G.; Strauch, A.R. Vascular smooth muscle α-actin expression as an indicator of parenchymal cell reprogramming in cardiac allografts. Transplantation 1998, 65, 1652-1656.
37. Suzuki, J.I.; Isobe, M.; Aikawa, M.; Kawauchi, M.; Shiojima, I.; Kobayashi, N.; Tojo, A.; Suzuki, T.; Kimura, K.; Nishikawa, T.; et al. Nonmuscle and smooth muscle myosin heavy chain expression in rejected cardiac allografts-A study in rat and monkey models. Circulation 1996, 94, 1118-1124.
38. Shi, C.W.; Russell, M.E.; Bianchi, C.; Newell, J.B.; Haber, E. Murine model of accelerated transplant arteriosclerosis. Circ. Res. 1994, 75, 199-207.
39. Todd, N.; Luzina, I.; Atamas, S. Molecular and cellular mechanisms of pulmonary fibrosis. Fibrogenesis Tissue Repair 2012, 5, 1-24.
40. Grotendorst, G.R.; Rahmanie, H.; Duncan, M.R. Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation. FASEB J. 2004, 18, 469-479.
41. Hinz, B.; Gabbiani, G. Mechanisms of force generation and transmission by myofibroblasts. Curr. Opin. Biotechnol. 2003, 14, 538-546.
42. Rock, J.R.; Barkauskas, C.E.; Cronce, M.J.; Xue, Y.; Harris, J.R.; Liang, J.; Noble, P.W.; Hogan, B.L.M. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc. Natl. Acad. Sci. USA 2011, 108, E1475-E1483.
43. Quaggin, S.E.; Kapus, A. Scar wars: Mapping the fate of epithelial-mesenchymal-myofibroblast transition. Kidney Int. 2011, 80, 41-50.
44. Knapp, A.M.; Ramsey, J.E.; Wang, S.X.; Strauch, A.R.; Kelm, R.J., Jr. Structure-function analysis of mouse Pur beta II. Conformation altering mutations disrupt single-stranded DNA and protein interactions crucial to smooth muscle alpha-actin gene repression. J. Biol. Chem. 2007, 282, 35899-35909.
45. Knapp, A.M.; Ramsey, J.E.; Wang, S.X.; Godburn, K.E.; Strauch, A.R.; Kelm, R.J.J. Nucleoprotein interactions governing cell type-dependent repression of the mouse smooth muscle alpha-actin promoter by single-stranded DNA-binding proteins Pur alpha and Pur beta. J. Biol. Chem. 2006, 281, 7907-7918.
46. Kelm, R.J., Jr.; Wang, S.X.; Polikandriotis, J.A.; Strauch, A.R. Structure/function analysis of mouse purβ, a single-stranded DNA-binding repressor of vascular smooth muscle α-actin gene transcription. J. Biol. Chem. 2003, 278, 38749-38757.
47. Carlini, L.E.; Getz, M.J.; Strauch, A.R.; Kelm, R.J., Jr. Cryptic MCAT enhancer regulation in fibroblasts and smooth muscle cells. Suppression of TEF-1 mediated activation by the singlestranded DNA-binding proteins, Purα, Purβ, and MSY1. J. Biol. Chem. 2002, 277, 8682-8692.
48. Cogan, J.G.; Subramanian, S.V.; Polikandriotis, J.A.; Kelm, R.J., Jr.; Strauch, A.R. Vascular smooth muscle α-actin gene transcription during myofibroblast differentiation requires Sp1/3 protein binding proximal to the MCAT enhancer. J. Biol. Chem. 2002, 277, 36433-36442.
49. Becker, N.A.; Kelm, R.J., Jr.; Vrana, J.A.; Getz, M.J.; Maher, L.J.I. Altered sensitivity to single-strand-specific reagents associated with the genomic vascular smooth muscle alpha-actin promoter during myofibroblast differentiation. J. Biol. Chem. 2000, 275, 15384-15391.
50. Kelm, R.J., Jr.; Cogan, J.G.; Elder, P.K.; Strauch, A.R.; Getz, M.J. Molecular interactions between single-stranded DNA-binding proteins associated with all essential MCAT element in the mouse smooth muscle α-actin promoter. J. Biol. Chem. 1999, 274, 14238-14245.
51. Kelm, R.J., Jr.; Elder, P.K.; Getz, M.J. The single-stranded DNA-binding proteins, Purα, Purβ, and MSY1 specifically interact with an exon 3-derived mouse vascular smooth muscle α-actin messenger RNA sequence. J. Biol. Chem. 1999, 274, 38268-38275.
52. Kelm, R.J., Jr.; Elder, P.K.; Strauch, A.R.; Getz, M.J. Sequence of cDNAs encoding components of vascular actin single-stranded DNA-binding factor 2 establish identity to Purα and Purβ. J. Biol. Chem. 1997, 272, 26727-26733.
53. Kelm, R.J., Jr.; Sun, S.; Strauch, A.R.; Getz, M.J. Repression of transcriptional enhancer factor-1 and activator protein-1-dependent enhancer activity by vascular actin single-stranded DNA binding factor 2. J. Biol. Chem. 1996, 271, 24278-24285.
54. Cogan, J.G.; Sun, S.; Stoflet, E.S.; Schmidt, L.J.; Getz, M.J.; Strauch, A.R. Plasticity of vascular smooth muscle α-actin gene transcription. Characterization of multiple, single-, and double-strand specific DNA-binding proteins in myoblasts and fibroblasts. J. Biol. Chem. 1995, 270, 11310-11321.
55. Sun, S.; Stoflet, E.S.; Cogan, J.G.; Strauch, A.R.; Getz, M.J. Negative regulation of the vascular smooth muscle α-actin gene in fibroblasts and myoblasts: disruption of enhancer function by sequence-specific single-stranded-DNA-binding proteins. Mol. Cell Biol. 1995, 15, 2429-2436.
56. Dooley, S.; Said, H.M.; Gressner, A.M.; Floege, J.; En-Nia, A.; Mertens, P.R. Y-box protein-1 is the crucial mediator of antifibrotic interferon-gamma effects. J. Biol. Chem. 2006, 281, 1784-1795.
57. Norman, J.T.; Lindahl, G.E.; Shakib, K.; En-Nia, A.; Yilmaz, E.; Mertens, P.R. The Y-box binding protein YB-1 suppresses collagen alpha 1(I) gene transcription via an evolutionarily conserved regulatory element in the proximal promoter. J. Biol. Chem. 2001, 276, 29880-29890.
58. Foster, D.N.; Min, B.; Foster, L.K.; Stoflet, E.S.; Sun, S.; Getz, M.J.; Strauch, A.R. Positive and negative cis-acting regulatory elements mediate expression of the mouse vascular smooth muscle α-actin gene. J. Biol. Chem. 1992, 267, 11995-12003.
59. Min, B.; Foster, D.N.; Strauch, A.R. The 5'-flanking region of the mouse vascular smooth muscle α-actin gene contains evolutionarily conserved sequence motifs within a functional promoter. J. Biol. Chem. 1990, 265, 16667-16675.
60. Johnson, E.M.; Kinoshita, Y.; Weinreb, D.B.; Wortman, M.J.; Simon, R.; Khalili, K.; Winckler, B.; Gordon, J. Role of Pur alpha in targeting mRNA to sites of translation in hippocampal neuronal dendrites. J. Neurosci. Res. 2006, 83, 929-943.
61. Hautmann, M.B.; Madsen, C.S.; Owens, G.K. A transforming growth factor β (TGFβ) control element drives TGFβ-induced stimulation of smooth muscle α-actin gene expression in concert with two CArG elements. J. Biol. Chem. 1997, 272, 10948-10956.
62. Tomasek, J.J.; McRae, J.; Owens, G.K.; Haaksma, C.J. Regulation of alpha-smooth muscle actin expression in granulation tissue myofibroblasts is dependent on the intronic CArG element and the transforming growth factor-beta1 control element. Am. J. Pathol. 2005, 166, 1343-1351.
63. Kawai-Kowase, K.; Ohshima, T.; Matsui, H.; Tanaka, T.; Shimizu, T.; Iso, T.; Arai, M.; Owens, G.K.; Kurabayashi, M. PIAS1 Mediates TGFβ-induced SM α-actin gene expression through inhibition of KLF4 function-expression by protein sumoylation. Arterioscler. Thromb. Vasc. Biol. 2009, 29, 99-106.
64. Csencsits, K.; Wood, S.C.; Lu, G.; Faust, S.M.; Brigstock, D.; Eichwald, E.J.; Orosz, C.G.; Bishop, D.K. Transforming growth factor beta-induced connective tissue growth factor and chronic allograft rejection. Am. J. Transplant. 2006, 6, 959-966.
65. Black, F.M.; Packer, S.E.; Parker, T.G.; Michael, L.H.; Roberts, R.; Schwartz, R.J.; Schneider, M.D. The vascular smooth muscle α-actin gene is reactivated during cardiac hypertrophy provoked by load. J. Clin. Invest. 1991, 88, 1581-1588.
66. Kuwahara, K.; Kinoshita, H.; Kuwabara, Y.; Nakagawa, Y.; Usami, S.; Minami, T.; Yamada, Y.; Fujiwara, M.; Nakao, K. Myocardin-related transcription factor A is a common mediator of mechanical stress-and neurohumoral stimulation-induced cardiac hypertrophic signaling leading to activation of brain natriuretic peptide gene expression. Mol. Cell. Biol. 2010, 30, 4134-4148.
67. Liu, N.; Bezprozvannaya, S.; Williams, A.H.; Qi, X.; Richardson, J.A.; Bassel-Duby, R.; Olson, E.N. microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev. 2008, 22, 3242-3254.
68. Mann, J.; Mann, D.A. Epigenetic regulation of wound healing and fibrosis. Curr. Opin. Rheumatol. 2013, 25, 101-107.
69. Hu, B.; Gharaee-Kermani, M.; Wu, Z.; Phan, S.H. Epigenetic regulation of myofibroblast differentiation by DNA methylation. Am. J. Pathol. 2010, 177, 21-28.
70. Hu, B.; Gharaee-Kermani, M.; Wu, Z.; Phan, S.H. Essential role of MeCP2 in the regulation of myofibroblast differentiation during pulmonary fibrosis. Am. J. Pathol. 2011, 178, 1500-1508.
71. Sandbo, N.; Kregel, S.; Taurin, S.; Bhorade, S.; Dulin, N.O. Critical role of serum response factor in pulmonary myofibroblast differentiation induced by TGF-β. Am. J. Respir. Cell Mol. Biol. 2009, 41, 332-338.
72. Elberg, G.; Chen, L.; Elberg, D.; Chan, M.D.; Logan, C.J.; Turman, M.A. MKL1 mediates TGF-β1-induced α-smooth muscle actin expression in human renal epithelial cells. Am. J. Physiol. Renal Physiol. 2008, 294, F1116-F1128.
73. Sotiropoulos, A.; Gineitis, D.; Copeland, J.; Treisman, R. Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. Cell 1999, 98, 159-169.
74. Sahai, E.; Alberts, A.S.; Treisman, R. RhoA effector mutants reveal distinct effector pathways for cytoskeletal reorganization, SRF activation and transformation. EMBO J. 1998, 17, 1350-1361.
75. Treisman, R.; Alberts, A.S.; Sahai, E. Regulation of SRF activity by Rho family GTPases. Cold Spring Harb. Symp. Quant. Biol. 1998, 63, 643-651.
76. Muehlich, S.; Wang, R.; Lee, S.M.; Lewis, T.C.; Dai, C.; Prywes, R. Serum-induced phosphorylation of the serum response factor coactivator MKL1 by the extracellular signal-regulated kinase 1/2 pathway inhibits its nuclear localization. Mol. Cell. Biol. 2008, 28, 6302-6313.
77. Zhang, H.Y.; Gharaee-Kermani, M.; Phan, S.H. Regulation of lung fibroblast alpha-smooth muscle actin expression, contractile phenotype, and apoptosis by IL-1 beta. J. Immunol. 1997, 158, 1392-1399.
78. Charbonney, E.; Speight, P.; Masszi, A.; Nakano, H.; Kapus, A. β-Catenin and Smad3 regulate the activity and stability of myocardin-related transcription factor during epithelial-myofibroblast transition. Mol. Biol. Cell 2011, 22, 4472-4485.
79. Masszi, A.; Speight, P.; Charbonney, E.; Lodyga, M.; Nakano, H.; Szaszi, K.; Kapus, A. Fate-determining mechanisms in epithelial-myofibroblast transition: Major inhibitory role for Smad3. J. Cell Biol. 2010, 188, 383-399.
80. Fan, L.; Sebe, A.; Peterfi, Z.; Masszi, A.; Thirone, A.C.P.; Rotstein, O.D.; Nakano, H.; McCulloch, C.A.; Szaszi, K.; Mucsi, I.; et al. Cell contact-dependent regulation of epithelialmyofibroblast transition via the Rho-Rho kinase-phospho-myosin pathway. Mol. Biol. Cell 2007, 18, 1083-1097.
81. Qiu, P.; Ritchie, R.P.; Fu, Z.; Cao, D.; Cumming, J.; Miano, J.M.; Wang, D.Z.; Li, H.J.; Li, L. Myocardin enhances Smad3-mediated transforming growth factor β1 signaling in a CArG box-independent manner: Smad-binding element is an important cis element for SM22α transcription in vivo. Circ. Res. 2005, 97, 983-991.
82. Qiu, P.; Feng, X.H.; Li, L. Interaction of Smad3 and SRF-associated complex mediates TGF-β1 signals to regulate SM22α transcription during myofibroblast differentiation. J. Mol. Cell. Cardiol. 2003, 35, 1407-1420.
83. Sandbo, N.; Lau, A.; Kach, J.; Ngam, C.; Yau, D.; Dulin, N.O. Delayed stress fiber formation mediates pulmonary myofibroblast differentiation in response to TGF-beta. Am. J. Physiol. Lung Cell. Mol. Physiol. 2011, 301, L656-L666.
84. 1-integrin in cardiac fibroblast by angiotensin II and transforming growth factor-β1. Am. J. Physiol. Cell Physiol. 2001, 281, C1457-C1467.
85. Hannigan, G.E.; Coles, J.G.; Dedhar, S. Integrin-linked kinase at the heart of cardiac contractility, repair, and disease. Circ. Res. 2007, 100, 1408-1414.
86. Lal, H.; Verma, S.K.; Foster, D.M.; Golden, H.B.; Reneau, J.C.; Watson, L.E.; Singh, H.; Dostal, D.E. Integrins and proximal signaling mechanisms in cardiovascular disease. Front. Biosci. 2009, 14, 2307-2334.
87. Ieda, M.; Tsuchihashi, T.; Ivey, K.N.; Ross, R.S.; Hong, T.T.; Shaw, R.M.; Srivastava, D. Cardiac fibroblasts regulate myocardial proliferation through β1 integrin signaling. Dev. Cell 2009, 16, 233-244.
88. Snead, A.N.; Insel, P.A. Defining the cellular repertoire of GPCRs identifies a profibrotic role for the most highly expressed receptor, protease-activated receptor 1, in cardiac fibroblasts. FASEB J. 2012, 26, 4540-4547.
89. Moustakas, A.; Heldin, C.H. Dynamic control of TGFβ signaling and its links to the cytoskeleton. FEBS Lett. 2008, 582, 2051-2065.
90. Zhao, X.H.; Laschinger, C.; Arora, P.; Szaszi, K.; Kapus, A.; McCulloch, C.A. Force activates smooth muscle α-actin promoter activity through the Rho signaling pathway. J. Cell Sci. 2007, 120, 1801-1809.
91. Olson, E.N.; Nordheim, A. Linking actin dynamics and gene transcription to drive cellular motile functions. Nat. Rev. Mol. Cell. Biol. 2010, 11, 353-365.
92. Thannickal, V.J.; Lee, D.Y.; White, E.S.; Cui, Z.; Larios, J.M.; Chacon, R.; Horowitz, J.C.; Day, R.M.; Thomas, P.E. Myofibroblast differentiation by transforming growth factor-beta1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase. J. Biol. Chem. 2003, 278, 12384-12389.
93. Shi-Wen, X.; Thompson, K.; Khan, K.; Liu, S.; Murphy-Marshman, H.; Baron, M.; Denton, C.P.; Leask, A.; Abraham, D.J. Focal adhesion kinase and reactive oxygen species contribute to the persistent fibrotic phenotype of lesional scleroderma fibroblasts. Rheumatology 2012, 51, 2146-2154.
94. Kim, Y.; Kugler, M.C.; Wei, Y.; Kim, K.K.; Li, X.; Brumwell, A.N.; Chapman, H.A. Integrin α3β1-dependent β-catenin phosphorylation links epithelial Smad signaling to cell contacts. J. Cell Biol. 2009, 184, 309-322.
95. Kim, K.K.; Wei, Y.; Szekeres, C.; Kugler, M.C.; Wolters, P.J.; Hill, M.L.; Frank, J.A.; Brumwell, A.N.; Wheeler, S.E.; Kreidberg, J.A.; et al. Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. J. Clin. Invest. 2009, 119, 213-224.
96. Popova, A.P.; Bentley, J.K.; Anyanwu, A.C.; Richardson, M.N.; Linn, M.J.; Lei, J.; Wong, E.J.; Goldsmith, A.M.; Pryhuber, G.S.; Hershenson, M.B. Glycogen synthase kinase-3β-β-catenin signaling regulates neonatal lung mesenchymal stromal cell myofibroblastic differentiation. Am. J. Physiol. Lung Cell. Mol. Physiol. 2012, 303, L439-L448.
97. Zhou, B.; Liu, Y.; Kahn, M.; Ann, D.K.; Han, A.; Wang, H.; Nguyen, C.; Flodby, P.; Zhong, Q.; Krishnaveni, M.S.; et al. Interactions between β-catenin and transforming growth factor-β signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP). J. Biol. Chem. 2012, 287, 7026-7038.
98. Vicencio, A.G.; Lee, C.G.; Cho, S.J.; Eickelberg, O.; Chuu, Y.; Haddad, G.G.; Elias, J.A. Conditional overexpression of bioactive transforming growth factor-beta1 in neonatal mouse lung: A new model for bronchopulmonary dysplasia? Am. J. Respir. Cell Mol. Biol. 2004, 31, 650-656.
99. Stanford University Target Genes of Wnt/beta-Catenin Signaling. Available online: http://stanford.edu/~rnusse/pathways/targets/ (accessed on 20 March 2013).
100. Stoflet, E.S.; Schmidt, L.J.; Elder, P.K.; Korf, G.M.; Foster, D.N.; Strauch, A.R.; Getz, M.J. Activation of a muscle-specific actin gene promoter in serum-stimulated fibroblasts. Mol. Biol. Cell 1992, 3, 1073-1083.
101. Medici, D.; Hay, E.D.; Olsen, B.R. Snail and Slug promote epithelial-mesenchymal transition through β-catenin-T-cell factor-4-dependent expression of transforming growth factor-β3. Mol. Biol. Cell 2008, 19, 4875-4887.
102. Willis, B.C.; Borok, Z. TGF-β-induced EMT: Mechanisms and implications for fibrotic lung disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 293, L525-L534.
103. Carthy, J.M.; Garmaroudi, F.S.; Luo, Z.; McManus, B.M. Wnt3a induces myofibroblast differentiation by upregulating TGF-β signaling through SMAD2 in a β-catenin-dependent manner. PLoS One 2011, 6, e19809.
104. Miyoshi, H.; Ajima, R.; Luo, C.T.; Yamaguchi, T.P.; Stappenbeck, T.S. Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury. Science 2012, 338, 108-113.
105. Zhang, P.; Cai, Y.; Soofi, A.; Dressler, G.R. Activation of Wnt11 by transforming growth factor-β drives mesenchymal gene expression through non-canonical Wnt protein signaling in renal epithelial cells. J. Biol. Chem. 2012, 287, 21290-21302.
106. Akhmetshina, A.; Palumbo, K.; Dees, C.; Bergmann, C.; Venalis, P.; Zerr, P.; Horn, A.; Kireva, T.; Beyer, C.; Zwerina, J.; et al. Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis. Nat. Commun. 2012, 3, doi:1038/ncomms1734.
107. Bosc, L.V.G.; Layne, J.J.; Nelson, M.T.; Hill-Eubanks, D.C. Nuclear factor of activated T cells and serum response factor cooperatively regulate the activity of an α-actin intronic enhancer. J. Biol. Chem. 2005, 280, 26113-26120.
108. Wang, J.W.; Niu, W.; Witte, D.P.; Chernausek, S.D.; Nikiforov, Y.E.; Clemens, T.L.; Sharifi, B.; Strauch, A.R.; Fagin, J.A. Overexpression of insulin-like growth factor-binding protein-4 (IGFBP-4) in smooth muscle cells of transgenic mice through a smooth muscle α-actin-IGFBP-4 fusion gene induces smooth muscle hypoplasia. Endocrinology 1998, 139, 2605-2614.
109. Wang, J.W.; Niu, W.; Nikiforov, Y.; Naito, S.; Chernausek, S.; Witte, D.; LeRoith, D.; Strauch, A.; Fagin, J.A. Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice. J. Clin. Invest. 1997, 100, 1425-1439.
110. Eder, P.; Molkentin, J.D. TRPC channels as effectors of cardiac hypertrophy. Circ. Res. 2011, 108, 265-272.
111. Davis, J.; Burr, A.; Davis, G.; Birnbaumer, L.; Molkentin, J. A TRPC6-dependent pathway for myofibroblast transdifferentiation and wound healing in-vivo. Dev. Cell 2012, 23, 705-715.
112. Nishida, M.; Onohara, N.; Sato, Y.; Suda, R.; Ogushi, M.; Tanabe, S.; Inoue, R.; Mori, Y.; Kurose, H. Gα12/13-mediated up-regulation of TRPC6 negatively regulates endothelin-1-induced cardiac myofibroblast formation and collagen synthesis through nuclear factor of activated T cells activation. J. Biol. Chem. 2007, 282, 23117-23128.
113. Zhang, G.Y.; Li, X.; Yi, C.G.; Pan, H.; He, G.D.; Yu, Q.; Jiang, L.F.; Xu, W.H.; Li, Z.J.; Ding, J.; et al. Angiotensin II activates connective tissue growth factor and induces extracellular matrix changes involving Smad/activation and p38 mitogen-activated protein kinase signaling pathways in human dermal fibroblasts. Exp. Dermatol. 2009, 18, 947-953.
114. Hecker, L.; Vittal, R.; Jones, T.; Jagirdar, R.; Luckhardt, T.R.; Horowitz, J.C.; Pennathur, S.; Martinez, F.J.; Thannickal, V.J. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat. Med. 2009, 15, 1077-1081.
115. Tomita, M.; Reinhold, M.I.; Molkentin, J.D.; Naski, M.C. Calcineurin and NFAT4 induce chondrogenesis. J. Biol. Chem. 2002, 277, 42214-42218.
116. Ly, D.L.; Waheed, F.; Lodyga, M.; Speight, P.; Masszi, A.; Nakano, H.; Hersom, M.; Pedersen, S.F.; Szaszi, K.; Kapus, A. Hyperosmotic stress regulates the distribution and stability of myocardin-related transcription factor, a key modulator of the cytoskeleton. Am. J. Physiol. Cell Physiol. 2013, 304, C115-C127.
117. Yamasaki, S.; Anderson, P. Reprogramming mRNA translation during stress. Curr. Opin. Cell Biol. 2008, 20, 222-226.
118. Yang, W.H.; Bloch, D.B. Probing the mRNA processing body using protein macroarrays and "autoantigenomics". RNA 2007, 13, 704-712.
119. Erlich, J.H.; Boyle, E.M.; Labriola, J.; Kovacich, J.C.; Santucci, R.A.; Fearns, C.; Morgan, E.N.; Yun, W.; Luther, T.; Kojikawa, O.; et al. Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation. Am. J. Pathol. 2000, 157, 1849-1862.
120. Holschermann, H.; Bohle, R.M.; Schmidt, H.; Zeller, H.; Fink, L.; Stahl, U.; Grimm, H.; Tillmanns, H.; Haberbosch, W. Hirudin reduces tissue factor expression and attenuates graft arteriosclerosis in rat cardiac allografts. Circulation 2000, 102, 357-363.
121. Mackman, N. The role of the tissue factor-thrombin pathway in cardiac ischemia-reperfusion injury. Semin. Vasc. Med. 2003, 3, 193-198.
122. Tullius, S.G.; Tilney, N.L. Both alloantigen-dependent and-independent factors influence chronic allograft rejection. Transplantation 1995, 59, 313-318.
123. Reusch, H.P.; Zimmermann, S.; Schaefer, M.; Paul, M.; Moelling, K. Regulation of Raf by Akt controls growth and differentiation in vascular smooth muscle cells. J. Biol. Chem. 2001, 276, 33630-33637.
124. Lasham, A.; Print, C.G.; Woolley, A.G.; Dunn, S.E.; Braithwaite, A.W. YB-1: Oncoprotein, prognostic marker and therapeutic target? Biochem. J. 2013, 449, 11-23.
125. Eliseeva, I.A.; Kim, E.R.; Guryanov, S.G.; Ovchinnikov, L.P.; Lyabin, D.N. Y-box-binding protein 1 (YB-1) and its functions. Biochemistry (Mosc.) 2011, 76, 1402-1433.
126. Kohno, K.; Izumi, H.; Uchiumi, T.; Ashizuka, M.; Kuwano, M. The pleiotropic functions of the Y-box-binding protein, YB-1. Bioessays 2003, 25, 691-698.
127. Evdokimova, V.; Ovchinnikov, L.P.; Sorensen, P.H. Y-Box binding protein 1: Providing a new angle on translational regulation. Cell Cycle 2006, 5, 1143-1147.
128. Johnson, E.M.; Daniel, D.C.; Gordon, J. The Pur protein family: Genetic and structural features in development and disease. J. Cell. Physiol. 2013, 228, 930-937.
129. Chen, N.; Onisko, B.; Napoli, J.L. The nuclear transcription factor RARα associates with neuronal RNA granules and suppresses translation. J. Biol. Chem. 2008, 283, 20841-20847.
130. Kanai, Y.; Dohmae, N.; Hirokawa, N. Kinesin transports RNA: Isolation and characterization of an RNA-transporting granule. Neuron 2004, 43, 513-525.
131. Zeng, L.H.; Fujimoto, T.; Kumamaru, E.; Irie, Y.; Miki, N.; Kuo, C.H. Characterization of novel Pur alpha-binding proteins in mouse brain. Neurochem. Int. 2004, 45, 753-758.
132. Minami, T.; Sugiyama, A.; Wu, S.Q.; Abid, R.; Kodama, T.; Aird, W.C. Thrombin and phenotypic modulation of the endothelium. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 41-53.
133. Steinina, O.I.; Poptic, E.J.; DiCorleto, P.E. Thrombin activates a Y box-binding protein (DNA-binding protein B) in endothelial cells. J. Clin. Invest. 2000, 106, 579-587.
134. Mertens, P.R.; Harendza, S.; Pollock, A.S.; Lovett, D.H. Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1. J. Biol. Chem. 1997, 272, 22905-22912.
135. Anderson, P. Post-transcriptional regulons coordinate the initiation and resolution of inflammation. Nat. Rev. Immunol. 2010, 10, 24-35.
136. Onishi, H.; Kino, Y.; Morita, T.; Futai, E.; Sasagawa, N.; Ishiura, S. MBNL1 associates with YB-1 in cytoplasmic stress granules. J. Neurosci. Res. 2008, 86, 1994-2002.
137. Goodier, J.L.; Zhang, L.; Vetter, M.R.; Kazazian, H.H., Jr. LINE-1 ORF1 protein localizes in stress granules with other RNA-binding proteins, including components of RNA interference RNA-induced silencing complex. Mol. Cell. Biol. 2007, 27, 6469-6483.
138. Matsumoto, S.; Uchiumi, T.; Saito, T.; Yagi, M.; Takazaki, S.; Kanki, T.; Kang, D. Localization of mRNAs encoding human mitochondrial oxidative phosphorylation proteins. Mitochondrion 2012, 12, 391-398.
139. Hanssen, L.; Frye, B.C.; Ostendorf, T.; Alidousty, C.; Djudjaj, S.; Boor, P.; Rauen, T.; Floege, J.; Mertens, P.R.; Raffetseder, U. Y-Box binding protein-1 mediates profibrotic effects of calcineurin inhibitors in the kidney. J. Immunol. 2011, 187, 298-308.
140. Wehner, K.A.; Schutz, S.; Sarnow, P. OGFOD1, a novel modulator of eukaryotic translation initiation factor 2 alpha phosphorylation and the cellular response to stress. Mol. Cell. Biol. 2010, 30, 2006-2016.
141. Kawaguchi, A.; Matsumoto, K.; Nagata, K. YB-1 Functions as a porter to lead influenza virus ribonucleoprotein complexes to microtubules. J. Virol. 2012, 86, 11086-11095.
142. Aumiller, V.; Graebsch, A.; Kremmer, E.; Niessing, D.; Forstemann, K. Drosophila Pur-alpha binds to trinucleotide-repeat containing cellular RNAs and translocates to the early oocyte. RNA Biol. 2012, 9, 633-643.
143. Ohashi, S.; Koike, K.; Omori, A.; Ichinose, S.; Ohara, S.; Kobayashi, S.; Sato, T.A.; Anzai, K. Identification of mRNA/protein (mRNP) complexes containing Puralpha, mStaufen, fragile X protein, and myosin Va and their association with rough endoplasmic reticulum equipped with a kinesin motor. J. Biol. Chem. 2002, 277, 37804-37810.
144. Hirokawa, N. mRNA transport in dendrites: RNA granules, motors, and tracks. J. Neurosci. 2006, 26, 7139-7142.
145. Nuutila, K.; Siltanen, A.; Peura, M.; Bizik, J.; Kaartinen, I.; Kuokkanen, H.; Nieminen, T.; Harjula, A.; Aarnio, P.; Vuola, J.; et al. Human skin transcriptome during superficial cutaneous wound healing. Wound Repair Regen. 2012, 20, 830-839.
146. Yingling, J.M.; Blanchard, K.L.; Sawyer, J.S. Development of TGF-beta signaling inhibitors for cancer therapy. Nat. Rev. Drug Discov. 2004, 3, 1011-1022.